Semi-Quantitative Analysis of Post-Transarterial Radioembolization 90Y Microsphere Positron Emission Tomography Combined with Computed Tomography (PET/CT) Images in Advanced Liver Malignancy: Comparison With 99mTc Macroaggregated Albumin (MAA) Single Photon Emission Computed Tomography (SPECT)
Authors:
- 14 September 2015
- journal article
- research article
- Published by Springer Nature in Nuclear Medicine and Molecular Imaging
- Vol. 50 (1) , 63-69
Abstract
Objectives The purpose of this study is to evaluate the correlation between pretreatment planning technetium-99m (99mTc) macroaggregated albumin (MAA) SPECT images and posttreatment transarterial radioembolization (TARE) yttirum-90 (90Y) PET/CT images by comparing the ratios of tumor-to-normal liver counts. Methods Fifty-two patients with advanced hepatic malignancy who underwent 90Y microsphere radioembolization from January 2010 to December 2012 were retrospectively reviewed. Patients had undergone 99mTc MAA intraarterial injection SPECT for a pretreatment evaluation of microsphere distribution and therapy planning. After the administration of 90Y microspheres, the patients underwent posttreatment 90Y PET/CT within 24 h. For semiquantitative analysis, the tumor-to-normal uptake ratios in 90Y PET/CT (TNR-yp) and 99mTc MAA SPECT (TNR-ms) as well as the tumor volumes measured in angiographic CT were obtained and analyzed. The relationship of TNR-yp and TNR-ms was evaluated by Spearman's rank correlation and Wilcoxon's matched pairs test. Results In a total of 79 lesions of 52 patients, the distribution of microspheres was well demonstrated in both the SPECT and PET/CT images. A good correlation was observed of between TNR-ms and TNR-yp (rho value = 0.648, p < 0.001). The TNR-yp (median 2.78, interquartile range 2.43) tend to show significantly higher values than TNR-ms (median 2.49, interquartile range of 1.55) (p = 0.012). The TNR-yp showed weak correlation with tumor volume (rho = 0.230, p = 0.041). Conclusions The 99mTc MAA SPECT showed a good correlation with 90Y PET/CT in TNR values, suggesting that 99mTc MAA can be used as an adequate pretreatment evaluation method. However, the 99mTc MAA SPECT image consistently shows lower TNR values compared to 90Y PET/CT, which means the possibility of underestimation of tumorous uptake in the partition dosimetry model using 99mTc MAA SPECT. Considering that 99mTc MAA is the only clinically available surrogate marker for distribution of microsphere, we recommend measurement of tumorous uptake using 90Y PET/CT should be included routinely in the posttherapeutic evaluation.Keywords
This publication has 31 references indexed in Scilit:
- Quantitative Comparison of PET and Bremsstrahlung SPECT for Imaging the In Vivo Yttrium-90 Microsphere Distribution after Liver RadioembolizationPLOS ONE, 2013
- Dosimetry Based on 99mTc-Macroaggregated Albumin SPECT/CT Accurately Predicts Tumor Response and Survival in Hepatocellular Carcinoma Patients Treated with 90Y-Loaded Glass Microspheres: Preliminary ResultsJournal of Nuclear Medicine, 2012
- Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastasesBritish Journal of Cancer, 2010
- Quantitative Analysis of 90 Y Bremsstrahlung SPECT-CT Images for Application to 3D Patient-Specific DosimetryCancer Biotherapy and Radiopharmaceuticals, 2009
- Evaluation of quantitative90Y SPECT based on experimental phantom studiesPhysics in Medicine & Biology, 2008
- Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratioJournal of Translational Medicine, 2007
- Yttrium-90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantationJournal of Surgical Oncology, 2006
- Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Selective internal radiation therapy: Distribution of radiation in the liverEuropean Journal of Cancer and Clinical Oncology, 1989